Goldman Sachs revamps the leadership lineup of its merger advisory business in Japan, naming Satoshi Yamagata and Masateru Takechi as co-heads in its latest push to expand in the country https://t.co/HXxwbTvj99 ...

Evercore will open an office in Saudi Arabia, becoming the latest investment bank to expand operations in the oil-rich kingdom as it’s in the midst of a trillion-dollar economic transformation https://t.co/kAPLerNtL0 ...

Nomura plans to relocate dozens of staff from its Tokyo headquarters to offices in cities such as London and New York to develop its homegrown talent for investment and sales operations https://t.co/enEqGpHNoC ...

One of Warren Buffett's key deputies is leaving Berkshire Hathaway. Todd Combs, the CEO of Berkshire-owned Geico, is joining JPMorgan to head up a new unit. The announcement comes alongside several executive changes ahead of Buffett's retirement as CEO. One of Warren Buffett's top lieutenants is leaving Berkshire Hathaway to join JPMorgan. Todd Combs, one of Buffett's two investment managers alongside Ted Weschler, and the CEO of Berkshire-owned Geico, will lead JPMorgan's $10 billion Strategic Inv ...

The Goldman Sachs Group, Inc. (NYSE:GS) is included among the 14 Best US Stocks to Buy for Long Term. Goldman Sachs (GS) Moves to Expand Asset Management With $2 Billion Innovator Acquisition Image by Steve Buissinne from Pixabay On December 1, The Goldman Sachs Group, Inc. (NYSE:GS) announced the acquisition of Innovator Capital Management, a defined outcome ETFs provider, for roughly $2 billion. The deal is a part of Goldman’s ongoing effort to scale up its asset management business. The acquisition i ...

Core Insights - Dominari Holdings Inc. has appointed Ambassador Jamie McCourt to its Advisory Board, enhancing its strategic leadership [2][3] - The company has withdrawn its previously filed $2 billion shelf registration statement, indicating confidence in its financial position and growth outlook [1][4] Group 1: Leadership Appointment - Ambassador Jamie McCourt brings extensive experience in global diplomacy, executive leadership, and entrepreneurship, having served as the U.S. Ambassador to France and as CEO of the Los Angeles Dodgers [2] - Her background includes roles in corporate law, investment, and angel investing, which will contribute to Dominari's strategic capabilities [2][3] Group 2: Financial Position - The withdrawal of the $2 billion shelf registration reflects the company's strong cash and marketable securities balance of $176.2 million and working capital of $198.8 million as of September 30, 2025 [3] - The decision underscores the company's confidence in its financial strength and strategic direction, allowing it to pursue growth initiatives without the need for additional capital [4] Group 3: Company Overview - Dominari Holdings Inc. operates in wealth management, investment banking, sales and trading, and asset management, focusing on enhancing shareholder value through organic growth and new opportunities [5] - The company aims to capitalize on emerging trends in the financial services sector and identify high-return investment opportunities [6]

JEF INVESTIGATION: Jefferies Financial Group Inc. Securities Fraud Investigation is Pending, Investors Notified to Contact BFA LawDecember 08, 2025 8:08 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed.If you in ...

Core Insights - The Dow Jones Industrial Average (DJIA) is up nearly 13% year to date, with leading stocks not being pure AI plays but rather companies like Caterpillar, Goldman Sachs, and IBM [1][2][3] Caterpillar (CAT) - Caterpillar has seen a significant stock increase of approximately 66.3% year to date, driven by strong global demand for construction and mining equipment [4] - Despite a decline in adjusted profits to $4.95 per share on $17.6 billion in sales, sales rose by 10% due to higher end-user equipment volumes [5] - The U.S. infrastructure push and lower interest rates have contributed to a substantial backlog, indicating sustained revenue visibility [6] - Caterpillar is also pivoting towards AI-enabling infrastructure, with partnerships that position it as a beneficiary of the tech boom [7] - Analysts view Caterpillar as a hybrid play, justifying a forward earnings multiple of 27 times [8] Goldman Sachs (GS) - Goldman Sachs ranks second among Dow leaders with a stock increase of over 49% year to date, attributed to a rebound in dealmaking and economic stability [9] - The third-quarter earnings were $12.25 per share on $15.2 billion in revenue, surpassing estimates [9][10] - The firm has advised on over $1 trillion in announced M&A volume this year, benefiting from sustained trading revenues and a healthy growth outlook [10] - Goldman Sachs' institutional focus allows it to capture upside from corporate optimism, driving shares to an all-time high of $856 [11] IBM (IBM) - IBM has achieved a 40% year-to-date gain, with shares nearing record closing highs of approximately $308 [12] - The turnaround is driven by software and consulting segments, with third-quarter revenue up 7% to $16.3 billion at constant currency [12] - The watsonx AI platform and Red Hat integration have boosted bookings and hybrid cloud adoption, with a consulting backlog of $31 billion [13] - IBM is also making strides in quantum computing and has raised full-year guidance to 5% growth and $14 billion in free cash flow [14]

Core Insights - Oppenheimer & Co. Inc. has strengthened its Biotech Research Team by hiring Kostas Biliouris as Managing Director, enhancing its long-standing expertise in the biotech sector [1][3] - Biliouris brings extensive experience from BMO Capital Markets and Morgan Stanley, along with a Ph.D. in biochemical engineering, which will contribute to Oppenheimer's research capabilities in genetic medicines and biotech [2][3] - The firm aims to expand its research coverage in biotech, an area characterized by rapid innovation, to better serve its institutional and corporate clients [3][4] Company Overview - Oppenheimer & Co. Inc. is a subsidiary of Oppenheimer Holdings Inc., providing a comprehensive range of wealth management, securities brokerage, and investment banking services [4] - The healthcare franchise, including biotechnology, pharmaceuticals, and medical technology, has been a core area of expertise for Oppenheimer [3]

Goldman’s purchase of an ETF fund manager isn’t about helping investors. It’s about keeping the fees flowing to Wall Street, Aaron Brown says (via @opinion) https://t.co/fly3TfBMIn ...